Details

NameSymbolSector
AARTI DRUGS LIMITEDAARTIDRUGSPharmaceuticals
Open
396.45
High
399.45
Low
392.5
Close
396.35
Volume
69625
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Aarti Drugs is  
Rickshaw Man
Estimated Stoploss of Aarti Drugs is ₹  
399.45
Aarti Drugs has a  
Bearishℹ
 pattern. 
Formation of  
Rickshaw Man
 candle pattern indicates the trend direction of Aarti Drugs is  
Unpredictableℹ
. 

Trend

Aarti Drugs is in  
Sideways trendℹ
. 
Price of Aarti Drugs is  
Downℹ
 by  

5.17

%. 
Target
Buy @ 

387.49

Sell @ 

441.25

Current @ 

396.35

Volume

The trade volumes of Aarti Drugs have become  
Deficientℹ
The volume trend for Aarti Drugs is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Aarti Drugs is  

Down

 by  

62.21

% 

Valuation

The current market price of Aarti Drugs is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 2574cr and total assets worth ₹ 2574cr, the balance sheet of Aarti Drugs is:  
Balancedℹ
. 
Cashflow
Aarti Drugs has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

0

%. 
49.8% i.e. ₹ 244cr earned in operatingℹ
33.47% i.e. ₹ 164cr spent in investingℹ
16.73% i.e. ₹ 82cr spent in financingℹ
0% in otherℹ
Aarti Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 
49.93% i.e. ₹ 358cr earned in operatingℹ
31.1% i.e. ₹ 223cr spent in investingℹ
18.97% i.e. ₹ 136cr spent in financingℹ
0% in otherℹ
Income
The income of Aarti Drugs is  

₹ 652cr

 and  

Profit

 is :  

₹ 45cr

Aarti Drugs Profit is down by:  

15.09

% and Income is Up by:  

10.51

% 
The income of Aarti Drugs is  

₹ 590cr

 and  

Profit

 is :  

₹ 53cr

Aarti Drugs Profit is down by:  

14.52

% and Income is Down by:  

12.98

% 
The income of Aarti Drugs is  

₹ 678cr

 and  

Profit

 is :  

₹ 62cr

Aarti Drugs Profit is up by:  

67.57

% and Income is Up by:  

19.37

% 
By using this site you agree to the use of cookies to deliver a better site experience.